Arrowhead Research | Ativo Circulante



Current Assets Alterar Data
Agios Pharmaceuticals USD 968.62M 3.02M 2025-03
Alnylam Pharmaceuticals USD 3.27B 27.03M 2025-03
Arrowhead Research USD 570.54M 124.93M 2024-12
Incyte USD 3.23B 7.24M 2025-03
Ionis Pharmaceuticals USD 2.42B 201.36M 2025-03
Ligand Pharmaceuticals USD 331.56M 22.17M 2024-12
Merck USD 38.78B 1.58B 2024-12
Moderna USD 6.77B 1.33B 2025-03
Novartis USD 29.7B 1.56B 2024-12
Sarepta Therapeutics USD 3.07B 388.09M 2024-12
TG Therapeutics USD 566.36M 7.71M 2024-12
Ultragenyx Pharmaceutical USD 817.12M 17.52M 2024-12
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12
Xencor USD 577.6M 4.27M 2024-12



Arrowhead Research Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.